Anti-™EM52B monoclonal antibody

Pre-made anti-™EM52B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM52B/™EM52B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2109-Ab-1/ GM-Tg-hg-IP2109-Ab-2Anti-Human ™EM52B monoclonal antibodyHuman
GM-Tg-rg-IP2109-Ab-1/ GM-Tg-rg-IP2109-Ab-2Anti-Rat ™EM52B monoclonal antibodyRat
GM-Tg-mg-IP2109-Ab-1/ GM-Tg-mg-IP2109-Ab-2Anti-Mouse ™EM52B monoclonal antibodyMouse
GM-Tg-cynog-IP2109-Ab-1/ GM-Tg-cynog-IP2109-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM52B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2109-Ab-1/ GM-Tg-felg-IP2109-Ab-2Anti-Feline ™EM52B monoclonal antibodyFeline
GM-Tg-cang-IP2109-Ab-1/ GM-Tg-cang-IP2109-Ab-2Anti-Canine ™EM52B monoclonal antibodyCanine
GM-Tg-bovg-IP2109-Ab-1/ GM-Tg-bovg-IP2109-Ab-2Anti-Bovine ™EM52B monoclonal antibodyBovine
GM-Tg-equg-IP2109-Ab-1/ GM-Tg-equg-IP2109-Ab-2Anti-Equine ™EM52B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2109-Ab-1/ GM-Tg-hg-IP2109-Ab-2; GM-Tg-rg-IP2109-Ab-1/ GM-Tg-rg-IP2109-Ab-2;
GM-Tg-mg-IP2109-Ab-1/ GM-Tg-mg-IP2109-Ab-2; GM-Tg-cynog-IP2109-Ab-1/ GM-Tg-cynog-IP2109-Ab-2;
GM-Tg-felg-IP2109-Ab-1/ GM-Tg-felg-IP2109-Ab-2; GM-Tg-cang-IP2109-Ab-1/ GM-Tg-cang-IP2109-Ab-2;
GM-Tg-bovg-IP2109-Ab-1/ GM-Tg-bovg-IP2109-Ab-2; GM-Tg-equg-IP2109-Ab-1/ GM-Tg-equg-IP2109-Ab-2
Products NameAnti-™EM52B monoclonal antibody
Formatmab
Target Name™EM52B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM52B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2109-Ag-1Recombinant multi-species ™52B/ ™EM52B/ C12orf59 protein
    ORF Viral VectorpGMLP004561human ™EM52B Lentivirus plasmid
    ORF Viral VectorvGMAP000478Human C12orf59 Adenovirus particle
    ORF Viral VectorvGMLP004561human ™EM52B Lentivirus particle
    ORF Viral VectorpGMAP000478Human C12orf59 Adenovirus plasmid
    ORF Viral VectorpGMLPm000950mouse Tmem52b Lentivirus plasmid
    ORF Viral VectorvGMLPm000950mouse Tmem52b Lentivirus particle


    Target information

    Target IDGM-IP2109
    Target Name™EM52B
    Gene ID120939,330428,689963,722332,611378,101086487,618567,100062403
    Gene Symbol and SynonymsC12orf59,C5H12orf59,D630042F21Rik,™EM52B
    Uniprot AccessionQ4KMG9
    Uniprot Entry Name™52B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165685
    Target ClassificationN/A

    The target: ™EM52B, gene name: ™EM52B, also named as C12orf59. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.